December 2011

ACC, SCAI call for more stenting oversight in Maryland amid new controversy ()
AHA stats: Risk factors for CVD, stroke may overtake treatment strides ()
ACC: Maximize claims acceptance, stay on top of CV coding changes ()
Good Intentions, Unintended Consequences ()
New Anticoagulants May Give Warfarin a Run for Its Money ()
ED as a Vascular Disease: Stents & Interventions ()
What Plagues the Cardiothoracic Surgery Administrator? ()
ACC Corner | Taking down Americas No. 1 Killer ()
Self-regulation Through Appropriate Use ()
Back Page | Extreme EVAR/TEVAR: Finding Off-label Solutions ()
CMAJ: PCI-CABG variability linked to physician preference, hospital ()
JACC: New onset of AF common after TAVI? ()
FDA upgrades Riata lead recall as Class 1 ()
JAMA: Antihypertensives can prolong death ()
FDA gives go-ahead to ST2 biomarker assay ()
Stroke: Antihypertensives reduce risk for patients with prehypertension ()
Simvastatin label revised, again ()
NEJM: Study on CHF readmission rates may inform policy ()
NEJM: Atorvastatin, not your generic rollout ()
14 more arrested in N.J. for alleged kickback scheme at MRI facility ()
Circ: Hospitals should re-evaluate IABP use in high-risk PCI ()
EHJ: Coxibs may be off the hook for CV risk, but not AF ()
Will quantitative imaging inch into practice in 2012? ()
FDA panel recommends CRT-D for mildy symptomatic HF patients ()
JAMA: Prostate cancer hormone therapy doesnt increase CV mortality ()
FDA investigates 'serious' bleeding events with Pradaxa ()
JACC: Obese STEMI patients continue to present 'paradox' ()
TAVR registry expected to serve as collaborative model ()
St. Jude Medical issues advisory, launches study ()
Circ: Mandating CMR stress tests for lower-risk ACS patients adds costs ()
AJC: Strategies needed to lower admissions for AF, flutter patients ()
Study: Enhancing acute stroke care can decrease costs ()
Lipitor loses patent; generic version is launched ()
Circ: Room for improvement in statin use for obstructive CAD patients ()